Page 3 - துறவி லூயிஸ் பல்கலைக்கழகம் பள்ளி ஆஃப் சட்டம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

I do not think that the waiver will help us overcoming the current vaccine shortage. The first problem is that there is not enough infrastructure – manufacturing facilities, equipment, personnel – to expand vaccine production to the levels it should be at to meet pandemic demand. In this context, altering the intellectual property status quo does little – Ana Santos Rutschman, assistant professor at the Saint Louis University School of Law pointed out in a conversation with Lénárd Sándor, researcher at the National University of Public Service. Ana Santos RUTSCHMAN is assistant professor at the Saint Louis University School of Law. She has published and presented widely on topics related to health law, food and drug regulation, intellectual property related to vaccines and other biotechnologies, innovation in the life sciences, and law and technology. She was a part of the COVID-19 Innovation Committee for the 2020 Biden presidential campaign. Her book, Vaccines as Tech

South africaUnited statesUnited kingdomInnovation committeeCambridge universitySaint louis university school of lawWorld health organizationVaccines as technologyCambridge university pressTechnology access poolJana santosSaint louis university schoolAccess poolSándor lénárdUs lawCovid 19